Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

BP 10-1 WASH

SODIUM SULFACETAMIDE and SULFUR
$0.3747per GM

Strength

100; 10 mg/g; mg/g

Manufacturer

Acella Pharmaceuticals, LLC

NDC

42192010406

Classification

Generic

Dosage Form

LIQUID

Route

TOPICAL

Last Updated

5/23/2013

Active Ingredients

SULFACETAMIDE SODIUM; SULFUR

Approval Type

Unapproved

On Market Since

6/4/2008

Pharmacological Classes

Sulfonamide Antibacterial
Sulfonamides

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

N/A

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

SULFAMETHOXAZOLE-TMP SS TABLET
Generic
60687060365•American Health Packaging
$0.0385
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
50268072815•AvPAK
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
53746027105•Amneal Pharmaceuticals of New York LLC
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
57237023201•Rising Pharma Holdings Inc.
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
57237023205•Rising Pharma Holdings Inc.
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
62135089718•Chartwell RX LLC
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
62135089790•Chartwell RX LLC
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
65162027110•Amneal Pharmaceuticals LLC
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
65162027150•Amneal Pharmaceuticals LLC
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
65862041901•Aurobindo Pharma Limited
$0.0394
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy